In recent years, liquid biopsy has emerged as a groundbreaking approach in the field of oncology, offering a minimally invasive alternative to traditional tissue biopsies. This cutting-edge technology enables the detection of cancer-related biomarkers from bodily fluids such as blood, urine, and saliva, providing real-time insights into disease progression, treatment response, and genetic mutations. With advancements in research tools, services, and diagnostics, liquid biopsy is revolutionizing cancer care and precision medicine.
